Literature DB >> 12511342

Early age-related maculopathy in the cardiovascular health study.

Ronald Klein1, Barbara E K Klein, Emily K Marino, Lewis H Kuller, Curt Furberg, Gregory L Burke, Larry D Hubbard.   

Abstract

OBJECTIVE: To describe the prevalence of early age-related maculopathy (ARM) and its relation to atherosclerosis, lipids, hypertension, and inflammatory factors in a population studied for cardiovascular disease risk factors and outcomes.
DESIGN: Population-based cohort study. PARTICIPANTS: A biracial population of 2361 adults (ranging from 69-97 years of age; 1998 whites and 363 blacks) living in four US counties (Allegheny County, Pennsylvania; Forsyth County, North Carolina; Sacramento County, California; and Washington County, Maryland) were examined during the interval from 1997 to 1998.
METHODS: Drusen and other lesions typical of ARM were identified by examining a 45 degrees color fundus photograph of one eye of each participant and classified by means of a modification of the Wisconsin Age-Related Maculopathy Grading System. MAIN OUTCOME MEASURES: Early ARM.
RESULTS: Early ARM was present in 15.5% and late ARM in 1.3% of the cohort. The overall prevalence of any ARM was lower in blacks (9.1%) compared with whites (18.2%). While controlling for age, race, gender, and total calories consumed in the diet, factors associated with ARM were cerebral white matter disease as detected by magnetic resonance imaging (odds ratio [OR], 1.50; 95% confidence interval [CI], 1.05, 2.16, P = 0.027), and lower serum total cholesterol (OR, per 10 mg/dl increase 0.95; 95% CI, 0.91, 0.98, P = 0.02). There were no associations between hypertension, blood pressure, common carotid artery plaque, or any systemic inflammatory factors studied and early ARM.
CONCLUSIONS: This population-based study documents the higher prevalence of ARM in whites compared with blacks. Although an association was found between signs of white matter disease and early ARM, there was no evidence of an association of ARM with either hypertension or inflammatory factors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12511342     DOI: 10.1016/s0161-6420(02)01565-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  48 in total

Review 1.  Epidemiology of age-related maculopathy: a review.

Authors:  Redmer van Leeuwen; Caroline C W Klaver; Johannes R Vingerling; Albert Hofman; Paulus T V M de Jong
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

2.  The relation between C reactive protein and age related macular degeneration in the Cardiovascular Health Study.

Authors:  G McGwin; T A Hall; A Xie; C Owsley
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

Review 3.  The role of inflammation in the pathogenesis of age-related macular degeneration.

Authors:  Larry A Donoso; David Kim; Arcilee Frost; Alston Callahan; Gregory Hageman
Journal:  Surv Ophthalmol       Date:  2006 Mar-Apr       Impact factor: 6.048

4.  Age-related macular degeneration and long-term risk of stroke subtypes.

Authors:  M Kamran Ikram; Paul Mitchell; Ronald Klein; A Rickey Sharrett; David J Couper; Tien Y Wong
Journal:  Stroke       Date:  2012-04-24       Impact factor: 7.914

5.  A prospective assessment of the Y402H variant in complement factor H, genetic variants in C-reactive protein, and risk of age-related macular degeneration.

Authors:  Debra A Schaumberg; William G Christen; Piotr Kozlowski; David T Miller; Paul M Ridker; Robert Y L Zee
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-06       Impact factor: 4.799

Review 6.  Progress in defining the molecular biology of age related macular degeneration.

Authors:  Andrew Lotery; Dorothy Trump
Journal:  Hum Genet       Date:  2007-07-21       Impact factor: 4.132

7.  [Age-related macular degeneration and risk of stroke].

Authors:  V Biousse; M-G Bousser; A Gaudric
Journal:  J Fr Ophtalmol       Date:  2008-01       Impact factor: 0.818

8.  Reconsidering the connection between vitamin D levels and age-related macular degeneration.

Authors:  S Golan; V Shalev; G Treister; G Chodick; A Loewenstein
Journal:  Eye (Lond)       Date:  2011-08-05       Impact factor: 3.775

9.  The prevalence and analysis of risk factors for age-related macular degeneration: 18-year follow-up data from the Speedwell eye study, United Kingdom.

Authors:  L-Y Ngai; N Stocks; J M Sparrow; R Patel; A Rumley; G Lowe; G Davey Smith; Y Ben-Shlomo
Journal:  Eye (Lond)       Date:  2011-03-25       Impact factor: 3.775

10.  Prospective study of incident age-related macular degeneration in relation to vigorous physical activity during a 7-year follow-up.

Authors:  Paul T Williams
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-19       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.